Crescent Grove Advisors’s Vanguard Value ETF VTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
6,853
+701
+11% +$140K 0.13% 120
2025
Q4
$1.17M Buy
6,152
+3
+0% +$564 0.11% 116
2025
Q3
$1.15M Hold
6,149
0.11% 110
2025
Q2
$1.09M Buy
6,149
+933
+18% +$158K 0.11% 108
2025
Q1
$901K Buy
5,216
+2,081
+66% +$363K 0.09% 112
2024
Q4
$531K Buy
3,135
+296
+10% +$51.9K 0.05% 155
2024
Q3
$496K Hold
2,839
0.05% 166
2024
Q2
$458K Hold
2,839
0.05% 173
2024
Q1
$462K Buy
2,839
+409
+17% +$63.1K 0.05% 191
2023
Q4
$363K Hold
2,430
0.04% 210
2023
Q3
$335K Sell
2,430
-6,905
-74% -$989K 0.04% 212
2023
Q2
$1.33M Sell
9,335
-180
-2% -$25K 0.14% 92
2023
Q1
$1.31M Hold
9,515
0.15% 90
2022
Q4
$1.34M Buy
9,515
+4,380
+85% +$603K 0.14% 93
2022
Q3
$634K Hold
5,135
0.07% 136
2022
Q2
$677K Buy
5,135
+2,525
+97% +$356K 0.07% 138
2022
Q1
$386K Hold
2,610
0.04% 195
2021
Q4
$384K Hold
2,610
0.04% 203
2021
Q3
$353K Hold
2,610
0.04% 187
2021
Q2
$359K Buy
+2,610
New +$359K 0.04% 174

Other funds holding VTV

Crescent Grove Advisors's VTV Position: Q1 2026 in Review

Crescent Grove Advisors increased its Vanguard Value ETF (VTV) stake by 11% in Q1 2026, buying an estimated $140K and bringing the position to 6,853 shares worth $1.34M. The position accounts for 0.13% of the portfolio, ranked #120.

Crescent Grove Advisors first reported a position in VTV in Q2 2021 and has held it in 20 quarters since. 2,698 funds tracked by Wall St. Rank hold VTV as of Q1 2026.

  • Crescent Grove Advisors held 6,853 shares of Vanguard Value ETF worth $1.34M as of Q1 2026.
  • Crescent Grove Advisors bought 701 Vanguard Value ETF shares in Q1 2026, an estimated $140K.
  • Vanguard Value ETF made up 0.13% of Crescent Grove Advisors's portfolio in Q1 2026, its #120 holding.
  • Crescent Grove Advisors first reported a position in Vanguard Value ETF in Q2 2021 and has held it in 20 quarters since.
  • 2,698 funds tracked by Wall St. Rank held Vanguard Value ETF as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.